Crossmark

Alpha-1 Antitrypsin Deficiency Severe and No Severe. Is It Benefit or Risk?

Crossref DOI link: https://doi.org/10.1016/j.arbres.2022.05.012

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Hernández Pérez, José María

López Charry, Claudia Vivian
License Information

Text and Data Mining valid from 2022-10-01
More Information

This article is maintained by: Elsevier

Article Title: Alpha-1 Antitrypsin Deficiency Severe and No Severe. Is It Benefit or Risk?

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2022.05.012

Content Type: simple-article

Copyright: © 2022 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.